comparemela.com

Today Epivax News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants

/PRNewswire/ Today EpiVax, Inc. ("EpiVax") confirmed that the company s EPV-CoV-19 vaccine epitopes are 98.2% conserved in the new Omicron SARS-CoV-2.

EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants

/PRNewswire/ Today EpiVax, Inc. ("EpiVax") confirmed that the company s EPV-CoV-19 vaccine epitopes are 98.2% conserved in the new Omicron SARS-CoV-2.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.